Effects of selective serotonin re-uptake inhibition on MOrbidity, mOrtality and mood in Depressed Heart Failure patients.
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2016
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms MOOD-HF
- 28 Jun 2016 Primary endpoint has not been met. (All-cause death or hospitalization), as per results published in the JAMA: the Journal of the American Medical Association.
- 28 Jun 2016 Results published in the JAMA: the Journal of the American Medical Association
- 16 Nov 2011 Status changed from completed to recruiting as reported by European Clinical Trials Database.